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ABSTRACT
We reported previously an approach for identifying
microRNA (miRNA)-target pairs by combining
miRNA and proteomic analyses. The approach was
applied in the present study to examine human renal
epithelial cells treated with transforming growth fac-
tor b1 (TGFb1), a model of epithelial–mesenchymal
transition important for the development of renal
interstitial fibrosis. Treatment of human renal epi-
thelial cells with TGFb1 resulted in upregulation of
16 miRNAs and 18 proteins and downregulation of
17 miRNAs and 16 proteins. Of the miRNAs
and proteins that exhibited reciprocal changes in
expression, 77 pairs met the sequence criteria
for miRNA–target interactions. Knockdown of
miR-382, which was up-regulated by TGFb1,
attenuated TGFb1-induced loss of the epithelial
marker E-cadherin. miR-382 was confirmed by
30-untranslated region reporter assay to target five
genes that were downregulated at the protein level
by TGFb1, including superoxide dismutase 2 (SOD2).
Knockdown of miR-382 attenuated TGFb1-induced
downregulation of SOD2. Overexpression of SOD2
ameliorated TGFb1-induced loss of the epithelial
marker. The study provided experimental evidence
in the form of reciprocal expression at the protein
level for a large number of predicted miRNA-target
pairs and discovered a novel role of miR-382
and SOD2 in the loss of epithelial characteristics
induced by TGFb1.
INTRODUCTION
MicroRNAs (miRNAs) are small regulatory RNA mol-
ecules encoded by speciﬁc genes in the genomes (1–5).
Typically, miRNAs bind to the 30-untranslated region
(UTR) of target mRNAs and decrease the abundance of
target proteins. The effect is mediated mainly by transla-
tional repression (6,7) and, in some cases, decreases in
mRNA abundance (8–11). Numerous studies have estab-
lished miRNAs as broad and powerful regulators of
protein expression in physiology and disease (11–15).
A major challenge in miRNA research is identiﬁcation
of speciﬁc target proteins (14,16). An miRNA could po-
tentially target multiple genes since its binding to 30-UTR
requires only partial complementarities. In silico sequence
analyses predicted several thousand proteins as potential
targets of miRNAs, providing a valuable starting point
(17–19). However, of the several hundred thousand pre-
dicted miRNA-target pairs in human, rat and mouse, only
a small fraction has been validated experimentally.
Experimental validation of miRNA-target pairs is labori-
ous and time consuming (16), considering the high rate of
‘hit and miss’ that many investigators have experienced.
The scarcity of miRNA-target pairs that are supported by
experimental evidence signiﬁcantly limits the ﬁeld of
miRNA research.
We recently developed a new approach for identifying
miRNA-target pairs by combining miRNA, proteomic
and bioinformatic analyses (20). A miRNA-target pair is
considered a high-probability pair if the miRNA and the
target protein are reciprocally expressed.
Treatment of renal epithelial cells with transforming
growth factor b1 (TGFb1) is a model commonly used to
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cells treated with TGFb1 undergo epithelial–mesenchymal
transition, a process that may contribute to the accumu-
lation of extracellular matrix proteins and the develop-
ment of interstitial ﬁbrosis in vivo. Interstitial ﬁbrosis is
a prominent feature of chronic renal injury in humans and
animal models and a strong predictor of the progression
of chronic renal disease in humans. Signs of epithelial–
mesenchymal transition have been detected in several
models of chronic renal injury including the Dahl
salt-sensitive rat (23).
Using the proteomic approach (20), we identiﬁed 77 pre-
dicted miRNA-target pairs that exhibited reciprocal
changes of expression in human renal epithelial cells in
response to TGFb1. Further experiments revealed a
novel role of miR-382 and its target superoxide dismutase
2 (SOD2) in TGFb1-induced loss of epithelial character-
istics in human kidney cells.
MATERIALS AND METHODS
Cell culture and TGFb1 treatment
HK-2, a human kidney epithelial cell line, was obtained
from and cultured as suggested by ATCC (20,24,25). Cells
at  40% conﬂuency were treated with recombinant
human TGFb1 (3ng/ml) (R&D Systems) or the vehicle
control in DMEM for the indicated time period.
MiRNA expression proﬁling
Expression levels of 376 human miRNAs were measured
by real-time reverse transcription polymerase chain
reaction (RT–PCR). Total RNA was extracted using
TRIzol (Invitrogen) from cells treated with TGFb1o r
vehicle for 24h. Small RNA was isolated using a
miRNA isolation kit and reverse-transcribed (200ng)
using a miRNA ﬁrst strand kit (SABiosciences). Real-
time PCR was performed in 384-well, human genome
miRNA PCR plates (SABiosciences) using a SYBR
Green/ROX qPCR master mix (SABiosciences) and the
ABI 7900HT instrument (Applied Biosystems). The
human genome miRNA PCR plate contained real-time
PCR primers for 376 human miRNAs, four normalizer
small RNAs and several quality controls. Three independ-
ent replicates, representing cells at two different passage
numbers, were analyzed for each treatment condition.
Each replicate sample was a pool of two dishes of cells.
Differences in miRNA levels were calculated using the
Ct method (25,26). The criteria of differential expres-
sion were P<0.02 and fold changes >20%, which had a
false positive rate of  10% calculated as described previ-
ously (20,23).
Taqman real-time PCR
Expression levels of several miRNAs and protein-coding
genes were quantiﬁed using real-time PCR with the
Taqman chemistry (Applied Biosystems) as described pre-
viously (11,20). To avoid any bias introduced during the
isolation of small RNA, total RNA samples were used in
these analyses. The 5S and 18S rRNA was used as internal
normalizer for miRNA and protein-coding genes,
respectively.
Differential in-gel electrophoresis and mass
spectrometry analysis
Proteomic analysis was performed using the differential
in-gel electrophoresis (DIGE) and mass spectrometry
method as described previously (20,24). Brieﬂy, protein
samples from vehicle or TGFb1 treated cells (n=4)
were labeled with CyDye DIGE Fluor minimal dyes Cy3
or Cy5 (GE Healthcare). The dyes were switched between
vehicle- and TGFb1-treated cells for every other gel. A
pool of all of the samples was labeled with Cy2. Three
labeled samples, including a vehicle-treated sample, a
TGFb1-treated sample and the pool, were combined and
separated on one gel by two-dimensional electrophoresis.
A total of four analytical gels were run to analyze four
pairs of control and TGFb1-treated samples. The protein
abundance was compared between vehicle- and TGFb1-
treated samples according to the intensity of each ﬂuores-
cent dye within a spot on the gels. Criteria for differential
expression were P<0.05, a difference >1.2-fold, and the
appearance of the spot in at least three of the four gels.
Differentially expressed protein spots were picked from
preparative gels. The identities of the proteins were
obtained using MALDI-TOF mass spectrometry
followed by Mascot searches with the settings described
previously (20,24).
Western blot
The relative abundance of several proteins was analyzed
using western blot as we described previously (11,25).
Coomassie blue staining of the entire membrane was
used to conﬁrm equal loading on the gel. Antibodies
were from Santa Cruz Biotechnology.
Bioinformatic analysis of MiRNA-target pairs
Bioinformatic analysis was performed as described previ-
ously (20). Reciprocal expression was deﬁned as a miRNA
being upregulated and a protein being downregulated in
the TGFb1-treated cells, or vice versa. Sequence-based
predictions of miRNA targets were retrieved from two
algorithms, TargetScan v5.1 (http://www.targetscan.org/)
and MicroCosm Targets v5 (http://www.ebi.ac.uk/
enright-srv/microcosm/htdocs/targets/v5/).
30-UTR reporter analysis
A3 0-UTR reporter analysis was performed to examine
interactions between speciﬁc miRNAs and target se-
quences, as we described previously (11). Brieﬂy, a
segment of the 30-UTR region of a miRNA target gene
was cloned into pMIR-REPORT luciferase plasmid
(Ambion).Each30-UTRreporterconstructwastransfected
into HeLa cells. Activities of luciferase and the internal
normalizer b-galactosidase, in the presence of a speciﬁc or
control anti-miR or pre-miR (Ambion), were measured
using the Dual-Light system (ABI) in a microplate format.
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Mutated or partially deleted 30-UTR reporter constructs
were generated using site-directed mutagenesis as we
described previously (27). In the mutated construct,
CAA in the miR-382 seed region-binding site within the
30-UTR segment of SOD2 were mutated to TGG. ACAA
in the seed region binding site were deleted in the partial
deletion construct.
Oligonucleotides
Locked nucleic acid (LNA)-modiﬁed anti-miR oligo-
nucleotides were obtained from Exiqon. Additional
anti-miR and pre-miR were obtained from Ambion.
HK2 cells were transfected with the oligonucleotides
(100nM) using Oligofectamine (Invitrogen).
Plasmid transfection
Superoxide dismutase 2 (SOD2) human cDNA ORF clone
was obtained from OriGene. The clone expresses SOD2
driven by a CMV promoter and tagged with C-terminal
Myc-DDK. The clone was ampliﬁed and puriﬁed using
techniques described previously (11,27). HK2 cells were
transfected with SOD2 plasmid or an empty vector (2mg
for each 3.5-cm dish) using Lipofectamine 2000.
Statistics
Data were analyzed using the Student’s t-test and
multiple-group analysis of variance (ANOVA). A
P<0.05 was considered signiﬁcant except in those
special cases described above. Data are shown as
mean±SEM.
RESULTS
TGFb1 substantially altered the MiRNA expression
proﬁle in HK2 cells
Treatment with TGFb1 (3ng/ml) for 24h resulted in
substantial alterations in the miRNA expression proﬁle
in HK2 cells, a human renal epithelial cell line. At a
permutation-based false positive rate of 10%, 16 of the
376 miRNAs examined were found upregulated and
17 downregulated (Figure 1A and Supplementary
Table S1). Nine miRNAs were altered by >4-fold,
including ﬁve that were altered by >10-fold. Our labora-
tory has examined changes in miRNA expression proﬁles
under various pathophysiological conditions in separate
studies. The changes in most cases were much more
modest than those observed in the present study.
The expression proﬁling was performed with
high-throughput real-time PCR using the SYBR Green
chemistry. Seven individual miRNAs, including four
downregulated, two upregulated and one not differentially
expressed, were further examined in an independent set of
RNA samples using the Taqman chemistry. As shown in
Figure 1B, individual real-time PCR analyses using the
Taqman chemistry conﬁrmed the result of the PCR
array analysis for all seven miRNAs.
TGFb1 altered the proteomic proﬁle in HK2 cells
Treatment with TGFb1 (3ng/ml) for 48h altered the
abundance of 34 proteins in HK2 cells. Approximately
2000 protein spots were detectable on each of the four
analytical DIGE gels. The intensities of 148 spots were
found to be signiﬁcantly different between vehicle- and
TGFb1-treated samples (n=4). MALDI-TOF analysis
successfully assigned identities to 97 of the 148 spots.
The 97 spots represented 34 distinct proteins, 18 of
which were upregulated by TGFb1 and 16 downregulated
(Table 1; see Supplementary Table S2 for additional
details of protein identiﬁcation). A recent study reported
that treatment of HK2 cells with TGFb1 at 2ng/ml for
48h resulted in the differential expression of 1207 genes at
the mRNA level (P<0.05 and fold change >2) (28). None
of the 34 proteins we identiﬁed was considered differen-
tially expressed at the mRNA level in that study.
The differentially expressed proteins shared several
functional themes including regulation of apoptosis,
RNA binding and gene transcription (Supplementary
Table S3). Many differentially expressed proteins are
involved in the cytoskeleton, mitochondria and endoplas-
mic reticulum. For example, seven mitochondrial proteins
were differentially expressed, including ATP5H, CTSD,
ECH1, ECHS1, HSPD1, PRDX3 and SOD2.
A protein was represented in multiple spots in several
cases. We have found apparent shifts of a protein on the
gel between experimental conditions in previous studies,
indicating changes in protein processing or modiﬁcation
(20,24). In the present study, however, spots representing
the same protein were invariably up- or downregulated in
the same direction by TGFb1. Data for only one repre-
sentative spot was shown in Table 1 and Supplementary
Table S1 in those cases.
Western blot analysis of tropomyosin 1 (TPM1) and
SOD2 was performed in protein samples independent of
those used in the proteomic analysis. The result (Figure 2)
conﬁrmed the upregulation of TPM1 and downregulation
of SOD2 in response to TGFb1. mRNA levels of TPM1
tended to be increased by TGFb1 (to 1.8±0.3-fold of
vehicle, n=6,P=0.07). SOD2 mRNA levels were signiﬁ-
cantly decreased by TGFb1 (to 24±3% of vehicle, n=6,
P<0.05). In the microarray study mentioned above (28),
TPM1 and SOD2 exhibited statistically signiﬁcant up- and
downregulation, respectively, but did not reach the
fold-change threshold of 2 used in that study.
MiRNA-target pairs supported by reciprocal expression
The differentially expressed miRNAs and proteins shown
in Figure 1 and Table 1 formed 578 pairs of reciprocally
expressed miRNAs and proteins. Of the 578 pairs, 77 were
predicted to be miRNA-target pairs according to
TargetScan v5.0 or MicroCosm Targets v5 based on
sequence characteristics (Table 2). The 77 pairs involved
31 miRNAs and 28 proteins.
Of the 28 proteins in Table 2, 11 were predicted targets
of at least three miRNAs. No signiﬁcant differences were
observed between the magnitude of expression changes of
these 11 proteins and the proteins that were predicted
targets of one or two miRNAs each.
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celerate mRNA degradation, leading to reciprocal expres-
sion of miRNAs and target mRNAs. Moreover, miRNAs
can sometimes be co-regulated with target mRNAs
possibly due to compensatory changes in the transcription
of target mRNAs. The differentially expressed miRNAs
we identiﬁed were compared with mRNA abundance data
from the study by Hills, et al. (28). The comparison
indicated several pairs of miRNAs and predicted target
mRNAs that were reciprocally regulated or co-regulated
by TGFb1 (Supplementary Table S4).
miR-382 contributed to TGFb1-induced loss of epithelial
characteristics of human renal cells
Treatment of HK2 cells with TGFb1 induced elongation
of the shape of the cells and a substantial loss of
E-cadherin expression, a marker of epithelial cells
(Figure 3A). The loss of epithelial characteristics is
typical of the early phase of epithelial–mesenchymal tran-
sition, a process importantly involved in the development
of renal interstitial ﬁbrosis (21,22).
miR-382 was substantially upregulated by TGFb1i n
HK2 cells (Figure 1). LNA anti-miR-382, compared
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Figure 1. TGFb1 had widespread effects on miRNA expression in human renal epithelial cells. HK2 cells were treated with vehicle or 3ng/ml of
TGFb1 for 24h. (A) 33 of the 376 miRNAs examined with real-time qPCR array were differentially expressed. n=3. See ‘Materials and Methods’
section for the criteria of differential expression. (B) Veriﬁcation of the result of miRNA expression proﬁling. RNA samples used for the individual
Taqman qPCR analysis were independent of those used in the high-throughput proﬁling with the SYBR Green qPCR array. n=3 for qPCR array,
n=4 for Taqman qPCR; *signiﬁcantly different from vehicle (P<0.05 for Taqman qPCR; see ‘Materials and Methods’ section for the criteria of
differential expression for qPCR array).
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knocked down the expression level of miR-382 in HK2
cells treated with TGFb1 (Figure 3B). The modesty of
the knockdown could be in part due to low transfection
efﬁciency as HK2 cells are difﬁcult to transfect.
Importantly, the partial knockdown of miR-382 resulted
in signiﬁcant attenuation of TGFb1-induced loss of
E-cadherin (Figure 3C), indicating that miR-382
upregulation contributed to TGFb1-induced loss of epi-
thelial characteristics.
miR-382 targeted SOD2
The protein abundance of ﬁve predicted miR-382 targets,
SOD2, NPM1, PSPC1, HSPD1 and ECH1, was reduced
by TGFb1 (Tables 1 and 2). We cloned a segment of the
30-UTR of SOD2. The segment included the predicted
miR-382 binding site (Table 3). The 30-UTR segment
was inserted into an expression construct downstream
from a luciferase reporter gene and transfected into Hela
cells. Luciferase activities were signiﬁcantly increased
when endogenous miR-382 was inhibited by an anti-
miR, compared with a control anti-miR (Figure 3D).
Anti-miR-382 did not have signiﬁcant effects on luciferase
Table 1. Proteins differentially expressed in HK2 cells in response to TGFb1
Common protein name Uniprot Gene symbol log2(T/C)
a P-value
Superoxide dismutase, mitochondrial P04179 SOD2  1.16 4.00E-05
60kDa heat shock protein, mitochondrial P10809 HSPD1  0.58 0.0095
T-complex protein 1 subunit gamma P49368 CCT3  0.44 0.012
Cathepsin D P07339 CTSD  0.41 0.0018
Endoplasmic reticulum protein ERp29 P30040 ERP29  0.41 0.0041
Lamin-A/C P02545 LMNA  0.39 0.0016
Heterogeneous nuclear ribonucleoprotein K P61978 HNRPK  0.38 0.0031
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial Q13011 ECH1  0.36 2.80E–05
Thioredoxin-dependent peroxide reductase, mitochondrial P30048 PRDX3  0.36 0.00036
ATP synthase D chain, mitochondrial O75947 ATP5H  0.34 0.0011
Nucleophosmin P06748 NPM1  0.32 0.0041
Heterogeneous nuclear ribonucleoprotein L P14866 HNRPL  0.30 0.0015
Paraspeckle component 1 Q8WXF1 PSPC1  0.29 0.0028
RNA-binding protein 8A Q9Y5S9 RBM8A  0.29 0.0059
Enoyl-CoA hydratase, mitochondrial P30084 ECHS1  0.28 0.016
Zinc ﬁnger protein 160 Q9HCG1 ZNF160  0.26 0.0012
Heterogeneous nuclear ribonucleoproteins A2/B1 P22626 HNRPA2B1 0.26 0.013
78-kDa glucose-regulated protein precursor P11021 HSPA5 0.26 0.029
Endoplasmic reticulum lipid raft-associated protein 2 O94905 ERLN2 0.28 0.0029
Protein disulﬁde-isomerase A3 P30101 PDIA3 0.30 0.018
Alpha-actinin-4 O43707 ACTN4 0.34 0.042
Tropomodulin-3 Q9NYL9 TMOD3 0.34 0.0044
Ezrin P15311 EZR 0.38 0.018
Heat shock protein HSP 90-beta P08238 HSP90AB1 0.41 0.02
Heterogeneous nuclear ribonucleoprotein D0 Q14103 HNRPD 0.42 0.031
Eukaryotic translation initiation factor 3 subunit I Q13347 EIF3I 0.43 0.017
Proliferation-associated protein 2G4 Q9UQ80 PA2G4 0.45 0.024
Actin, cytoplasmic 1 P60709 ACTB 0.46 0.0015
Eukaryotic initiation factor 4A-I P60842 EIF4A1 0.50 0.0084
Tubulin beta chain P07437 TUBB 0.55 0.025
Membrane-organizing extension spike protein P26038 MSN 0.58 0.016
Keratin, type I cytoskeletal 18 P05783 KRT18 0.59 0.0021
Tubulin alpha-1B chain P68363 TUBA1B 0.59 0.019
Tropomyosin alpha-1 chain P09493 TPM1 1.87 0.00088
HK2 cells were treated with vehicle (C) or 3ng/ml TGFb1 (T) for 48h. Differentially expressed proteins were identiﬁed by DIGE and mass
spectrometry analysis. n=4. Additional information about protein identiﬁcation and functional annotation is available in Supplementary Tables
S2 and S3.
aT/C, TGFb1-treated/vehicle control.
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partially deleted (Figure 3D). Anti-miR-382 also increased
luciferase activities when the luciferase gene was linked
to a 30-UTR segment cloned from NPM1, PSPC1,
HSPD1 or ECH1 (Table 3). The increase ranged from
1.33- to 3.01-fold at 24 or 48h after transfection (n=4,
two-way ANOVA P<0.05 for each target gene). It sug-
gested that endogenous miR-382 in HeLa cells suppressed
the expression of luciferase gene by interacting with the
30-UTR of each of the ﬁve predicted targets.
In HK2 cells, a miR-382 mimic signiﬁcantly decreased
luciferase activity when the cells were transfected with the
reporter construct containing the 30-UTR segment of
SOD2. Again, mutations or partial deletion in the seed
region-binding site abrogated the effect of the miR-382
mimic (Figure 3E). A miR-382 mimic, instead of an
anti-miR, was used in these experiments because basal
levels of miR-382 in HK2 cells that were not treated
with TGFb1 were not further reduced by the anti-miR
(Figure 3B).
miR-485-3p and miR-200a* were two other miRNAs
predicted to regulate SOD2 and showing reciprocal regu-
lation by TGFb1 compared with SOD2 (Table 2). SOD2
30-UTR reporter analysis, however, showed that
anti-miR-485-3p, compared with control anti-miR, did
not signiﬁcantly change luciferase activities in Hela cells
[7±27%, n=4, non-signiﬁcant (NS)] or HK2 cells
(5±20%, n=4, NS). Similarly, anti-miR-200a* did not
signiﬁcantly change luciferase activities ( 2±7% in Hela
cells,  18±13% in HK2 cells, n=5, NS). The 30-UTR
construct used for the miR-382 experiment (Table 3)
contained a predicted miR-485-3p binding site in SOD2
transcript variant 1 (NM_000636) and was used for the
miR-485-3p experiment. A separate 30-UTR construct
containing a predicted miR-200a* binding site was
used for the miR-200a* experiment. The construct
spanned nucleotides 20–199 of SOD2 transcript variant
3 (NM_001024466).
Knockdown of miR-382 signiﬁcantly attenuated
TGFb1-induced downregulation of SOD2 (Figure 3F).
A myc-DDK-tagged construct, driven by a CMV
promoter, was used to overexpress SOD2 in HK2 cells
(Figure 4A). Overexpression of SOD2 attenuated
Table 2. MiRNA-target pairs supported by sequence characteristics
and reciprocal expression in human renal epithelial cells treated with
TGFb1
miRNA miRNA
log2(T/C)
a
Protein
target
Protein
log2(T/C)
Target
Scan
Micro
Cosm
hsa-miR-346 4.78 LMNA  0.39 Yes
hsa-miR-485-3p 4.63 SOD2  1.16 Yes
hsa-miR-514 4.12 PSPC1  0.29 Yes
hsa-miR-514 4.12 RBM8A  0.29 Yes
hsa-miR-369-5p 3.88 ZNF160  0.26 Yes
hsa-miR-369-5p 3.88 CCT3  0.44 Yes
hsa-miR-629 3.82 CCT3  0.44 Yes
hsa-miR-629 3.82 CTSD  0.41 Yes
hsa-miR-767-5p 3.17 ZNF160  0.26 Yes Yes
hsa-miR-767-5p 3.17 RBM8A  0.29 Yes
hsa-miR-767-5p 3.17 HNRNPL  0.3 Yes
hsa-miR-767-5p 3.17 NPM1  0.32 Yes
hsa-miR-767-5p 3.17 LMNA  0.39 Yes
hsa-miR-382 2.86 PSPC1  0.29 Yes
hsa-miR-382 2.86 NPM1  0.32 Yes
hsa-miR-382 2.86 ECH1  0.36 Yes
hsa-miR-382 2.86 HSPD1  0.58 Yes Yes
hsa-miR-382 2.86 SOD2  1.16 Yes Yes
hsa-miR-323-3p 2.34 PSPC1  0.29 Yes
hsa-miR-323-3p 2.34 HNRNPK  0.38 Yes Yes
hsa-miR-379 1.97 RBM8A  0.29 Yes
hsa-miR-376c 1.93 PSPC1  0.29 Yes
hsa-miR-376c 1.93 RBM8A  0.29 Yes
hsa-miR-376c 1.93 ECH1  0.36 Yes
hsa-miR-376c 1.93 PRDX3  0.36 Yes Yes
hsa-miR-376c 1.93 HNRNPK  0.38 Yes
hsa-miR-188-3p 1.87 ZNF160  0.26 Yes
hsa-miR-188-3p 1.87 PSPC1  0.29 Yes
hsa-miR-188-3p 1.87 ERP29  0.41 Yes
hsa-miR-493 1.75 ZNF160  0.26 Yes
hsa-miR-493 1.75 HNRNPL  0.3 Yes
hsa-miR-127-5p 1.01 ZNF160  0.26 Yes
hsa-miR-127-5p 1.01 RBM8A  0.29 Yes
hsa-miR-200a* 0.77 HNRNPK  0.38 Yes
hsa-miR-200a* 0.77 SOD2  1.16 Yes
hsa-miR-132 0.73 HNRNPL  0.3 Yes
hsa-miR-132 0.73 SOD2  1.16 Yes Yes
hsa-miR-455-3p 0.61 RBM8A  0.29 Yes
hsa-miR-455-3p 0.61 CTSD  0.41 Yes
hsa-miR-182  0.43 HSPA5 0.26 Yes
hsa-miR-182  0.43 ERLIN2 0.28 Yes
hsa-miR-182  0.43 MSN 0.58 Yes
hsa-let-7i  0.51 HSPA5 0.26 Yes
hsa-let-7i  0.51 PDIA3 0.3 Yes
hsa-let-7i  0.51 TUBB 0.55 Yes
hsa-let-7i  0.51 MSN 0.58 Yes
hsa-miR-9  0.62 ERLIN2 0.28 Yes
hsa-miR-9  0.62 MSN 0.58 Yes
hsa-miR-26a  0.69 HNRNPA2B1 0.26 Yes
hsa-miR-26a  0.69 EIF3I 0.43 Yes
hsa-miR-93  0.7 HSPA5 0.26 Yes
hsa-miR-425  0.73 HNRNPD 0.42 Yes Yes
hsa-miR-28-3p  0.85 HNRNPA2B1 0.26 Yes
hsa-miR-28-3p  0.85 TMOD3 0.34 Yes Yes
hsa-miR-28-3p  0.85 HSP90AB1 0.41 Yes
hsa-miR-30b  0.95 HNRNPA2B1 0.26 Yes
hsa-miR-30b  0.95 HSPA5 0.26 Yes
hsa-miR-222  1.05 HNRNPD 0.42 Yes Yes
hsa-miR-222  1.05 MSN 0.58 Yes
hsa-miR-192  1.05 HSPA5 0.26 Yes
hsa-miR-192  1.05 ERLIN2 0.28 Yes
hsa-miR-192  1.05 MSN 0.58 Yes
hsa-miR-26b  1.24 HNRNPA2B1 0.26 Yes
hsa-miR-26b  1.24 EIF3I 0.43 Yes
hsa-miR-103  1.27 HNRNPA2B1 0.26 Yes
(continued)
Table 2. Continued
miRNA miRNA
log2(T/C)
a
Protein
target
Protein
log2(T/C)
Target
Scan
Micro
Cosm
hsa-miR-103  1.27 ERLIN2 0.28 Yes
hsa-miR-103  1.27 EZR 0.38 Yes
hsa-miR-103  1.27 TPM1 1.87 Yes Yes
hsa-miR-146b-5p  1.41 ERLIN2 0.28 Yes
hsa-miR-146b-5p  1.41 HNRNPD 0.42 Yes Yes
hsa-miR-146b-5p  1.41 PA2GA 0.45 Yes
hsa-miR-138  1.68 ERLIN2 0.28 Yes
hsa-miR-138  1.68 ACTN4 0.34 Yes
hsa-miR-138  1.68 EZR 0.38 Yes
hsa-miR-138  1.68 MSN 0.58 Yes
hsa-miR-34a  2.39 HSPA5 0.26 Yes
hsa-miR-34a  2.39 TUBB 0.55 Yes
aT/C, TGFb1-treated/vehicle control.
Nucleic Acids Research, 2010,Vol.38, No. 22 8343TGFb1-induced loss of E-cadherin (Figure 4B). The data
suggested that SOD2 was protective against TGFb1-
induced loss of epithelial characteristics. In TGFb1-
treated cells, endogenous SOD2 was suppressed in part
by upregulated miR-382.
DISCUSSION
We have provided experimental evidence in the form of
reciprocal expression at the protein level for 77 predicted
miRNA-target pairs, ﬁve of which were further validated
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Figure 3. miR-382 targeted SOD2 and contributed to TGFb1-induced loss of epithelial characteristics in human renal epithelial cells. (A) TGFb1
induced loss of epithelial characteristics in HK2 cells as indicated by typical changes in cell morphology and a suppression of E-cadherin mRNA, an
epithelial marker. TGFb1 was used at 3ng/ml for 48h. N=6,*P<0.05. (B) Knockdown of miR-382. HK2 cells were treated with vehicle or TGFb1
in the presence of LNA anti-miR-382 or LNA scrambled control anti-miR (100nM). n=6,*P<0.05 vs. no treatment;
#P<0.05 versus TGFb1 plus
control anti-miR. (C) Knockdown of miR-382 attenuated the suppression of E-cadherin mRNA by TGFb1. n=6–9, *P<0.05 versus control
anti-miR. (D) miR-382 interacted with the 30-UTR of SOD2 in Hela cells. Hela cells were transfected with luciferase reporter constructs containing a
30-UTR segment of SOD2 or a mutated (SOD2-mut) or partially deleted (SOD2-del) segment. The mutations and deletion were described in the text.
The effect of anti-miR-382 (100nM) compared to control, scramble anti-miR was shown. n=4, *P<0.05 versus control anti-miR. (E) miR-382
interacted with 30-UTR of SOD2 in HK2 cells. HK2 cells were transfected with luciferase reporter constructs as described above. The effect of
pre-miR-382 (100nM), a miR-382 mimic, compared with control, scramble pre-miR was shown. n=4,*P<0.05 versus control pre-miR. (F) SOD2
expression was suppressed by TGFb1, but partially restored by knockdown of miR-382. miR-382 in TGFb1-treated HK2 cells was knocked down
with LNA anti-miR (see Figure 3B). n=6, *P<0.05 vs. control anti-miR.
8344 Nucleic Acids Research, 2010,Vol.38, No. 22with 30-UTR reporter analyses. Moreover, we demon-
strated a novel role of miR-382 and SOD2 in TGFb1-
induced loss of epithelial characteristics in human
kidney cells.
The 77 pairs represent a substantial expansion of human
miRNA-target pairs that are supported by reciprocal
expression with the target examined at the protein level.
Many studies of miRNA function would begin by identify-
ing miRNAs that are differentially expressed under an
experimental or disease condition. The next step is to
identify target genes for the differentially expressed
miRNAs. Deﬁnitive evidence for a miRNA-target pair
consists of sequence characteristics, reciprocal expression,
and 30-UTR response. MiRNA-target pairs such as those
reported in the present study would help to substantially
narrow down the long list of sequence-based, predicted
targets. It could accelerate miRNA studies by enabling
investigators to focus on high-probability targets when
performing laborious 30-UTR and functional analysis.
In addition, substantial expansion of experimentally
supported miRNA-target pairs will provide an increasingly
larger basis upon which algorithms for miRNA target
prediction could be improved (29).
Our ﬁndings highlight the importance of considering
multiple factors when studying the effect of an miRNA.
We were able to conﬁrm 5 of the 77 predicted pairs, all of
which involved miR-382. However, two predicted pairs
involving miR-485-3p and miR-200a* regulation of
SOD2 were not conﬁrmed. miR-485-3p had a large fold
change following the TGFb1 treatment, but its abun-
dance, estimated from the PCR data, was approximately
one order of magnitude lower than miR-382. miR-200a*
appeared more abundant than miR-382, yet its change
in response to TGFb1 was much smaller. In addition,
transcriptional regulation cannot be ruled out for
some of the target genes. Many factors, including abun-
dance, relative change, binding kinetics, sub-cellular local-
ization, characteristics of speciﬁc target sequences and the
cellular milieu, could conceivably inﬂuence the effect of a
miRNA.
The approach of identifying miRNA-target pairs by
simultaneous analysis of miRNA and proteomic proﬁles
under physiological conditions was developed by our
laboratory recently (20). The approach may be less
speciﬁc compared with studies using experimental
overexpression of an individual miRNA (32–36). The
advantage of our approach is that we are detecting physio-
logical or pathophysiological up- and downregulation of
miRNAs and their target proteins. High-throughput
analysis of miRNA targets has been performed mostly
at the mRNA level (9,29–31). Current technologies for
quantitative proteomics provide only a partial coverage
of a cellular proteome, but have the signiﬁcant advantage
of examining the ﬁnal effect of miRNA action since some
miRNAs could inhibit translation without altering mRNA
abundance. The DIGE/mass spectrometry approach used
in the present study is limited in its ability to detect
membrane proteins, low-abundance proteins and
proteins with extreme molecular weights or isoelectric
points. However, the approach has exceptional power
for comparative and quantitative analysis compared with
other proteomic approaches.
Table 3. 30-UTR reporter constructs
Target miR-382 target site P-value 30-UTR segment primer sequences
SOD2 120 to 136 0.015 27 to 289 Forward: 5-AAGCTCTTTATGACTGTTTTTGTAG-3;
Reverse: 5-ATGGATGGAATATTTTTGATGG-3
NPM1 1 to 20 0.048  66 to 144 Forward: 5-AATTGCTTCCGGATGACTGAC-3;
Reverse: 5-CTTGGCAATAGAACCTGGACA-3
PSPC1 284 to 303 0.011 58 to 353 Forward: 5-TTTACCTGTTATCTGGAAGAAATG-3;
Reverse: 5-TACAGCAAAGTTTAGTAAGACCGT-3
HSPD1 56 to 76 0.010 18 to 424 Forward: 5-TACCTTTATTAATGAACTGTGAC-3;
Reverse: 5-CATAATTGGATACTTCTCTACTTTGT-3
ECH1 102 to 124 0.002 36 to 185 Forward: 5-GCCTTGTCCCGCCTCAT-3;
Reverse: 5-ACTTTGCTTTATTGTTTGTGG-3
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Figure 4. SOD2 was protective against TGFb1-induced loss of epithe-
lial characteristics. (A) Overexpression of SOD2 with a Myc-
DDK-tagged plasmid (pSOD2). HK2 cells were not transfected (NT)
or were transfected with pSOD2 or an empty vector (2mg for each
3.5-cm dish). Western blot was performed 24h later using an SOD2
antibody. (B) Overexpression of SOD2 attenuated TGFb1-induced
downregulation of E-cadherin. n=5, *P<0.05.
Nucleic Acids Research, 2010,Vol.38, No. 22 8345The present study was the ﬁrst to characterize miRNA
and proteomic responses to TGFb1 in renal epithelial
cells. Responses of miRNAs or proteomes to TGFb1
have been examined by several recent studies of metastatic
epithelial–mesenchymal transition (38–44). Effect of
TGFb1 on miRNAs in glomerular mesangial cells has
also been reported (45). There are some overlaps
between the result of the present study and studies of
metastatic models, including downregulation of miR-192
and mitochondrial 60kD heat-shock protein (HSPD1)
and upregulation of TPM1, meosin (MSN) and tubulin
a1 chain (TUBA1B) (37,40,41,44). Most of the miRNAs
and proteins identiﬁed in the present study, however, have
not been reported as responsive to TGFb1 in metastatic
models. It suggests that much of the effect of TGFb1
observed in the present study might be speciﬁc to renal
tubulointerstitial ﬁbrosis.
The role of miR-382 and SOD2 in TGFb1-induced loss
of epithelial characteristics was a novel ﬁnding.
Mitochondrial oxidative stress has been reported to be
involved in epithelial–mesenchymal transition in renal epi-
thelial cells (46). Renal oxidative stress is a prominent
feature of models of chronic renal injury including the
Dahl salt-sensitive rat, which exhibits signiﬁcant signs of
epithelial–mesenchymal transition (23). We have now
shown that TGFb1 downregulates SOD2, an enzyme im-
portant for the protection against mitochondrial oxidative
stress, while overexpression of SOD2 is protective against
TGFb1-induced loss of epithelial characteristics.
Moreover, the downregulation of SOD2 induced by
TGFb1 is at least in part mediated by upregulation of
miR-382. These novel ﬁndings reveal a possible, new
mechanism of epithelial–mesenchymal transition that
involves upregulation of miR-382, leading to SOD2
downregulation and oxidative stress. The interplay
between this new mechanism and other molecular
pathways known to be involved in epithelial mesenchymal
transition (21,22), as well as the in vivo signiﬁcance of this
new pathway, warrants further investigation in future
studies.
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